Plain-English translation of NCT06725277 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This is a long-term study that follows people with severe depression who aren't responding to standard antidepressants. Researchers want to compare two forms of ketamine therapy — (a nasal spray) and (given through a vein) — to understand which one works better for different people, how satisfied patients are with each approach, and what side effects occur over time.
When standard antidepressants don't work after trying at least two different medications, people need other options. This medication has shown promise for severe depression, but doctors need real-world information about how well each form works long-term, whether people can stick with it, and how safe it is over years of use.
You likely qualify if…
You likely don't qualify if…
You'll receive one of the two ketamine treatments as prescribed by your doctor at one of six study sites (academic hospitals or community mental health clinics). Over five years, you'll complete regular surveys and check-ins about how you're feeling, how satisfied you are with the treatment, and any side effects you notice. The study tracks your progress without changing your regular care — it's designed to gather real-world information about what happens when people use these treatments over the long term.
AI-generated summary from trial data · Sep 16, 2026 · Not medical advice
United States